Communiqués AbbVie Inc.

Actions

ABBV

US00287Y1091

Marché Fermé - Nyse Autres places de cotation 22:05:15 31/05/2024			Varia. 5j.	Varia. 1 janv.
161,2 ^USD	+3,15 %		+2,66 %	+4,05 %

31/05	Les valeurs de la santé sont stables ou en hausse avant la cloche du vendredi	MT
31/05	AbbVie reçoit la recommandation du comité de l'Agence européenne du médicament pour l'approbation d'un candidat-médicament contre les maladies intestinales graves	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis	31/05	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	21/05	AQ
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week	20/05	AQ
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders	13/05	PR
QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults	08/05	AQ
AbbVie to Present at the Bank of America Securities Healthcare Conference	06/05	PR
AbbVie : Reinforces Commitment to Science and Innovation with a €150 million Euro Investment in New Cutting-Edge Research and Development Facility in Germany	30/04	PU
AbbVie: Q1 Earnings Snapshot	26/04	AQ
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study	25/04	PR
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX Cosmetic and Their Other Biggest Brands	24/04	AQ
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands	23/04	PR
AbbVie - Phase 3 SELECT-GCA Study of Upadacitinib showed Positive Results in Patients with Giant Cell Arteritis	19/04	AQ
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis	18/04	PR
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant for Preventive Treatment of Migraine	15/04	AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors	12/04	BU
Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors	12/04	BU
The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors	10/04	BU
SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne	09/04	PR
AbbVie to Host First-Quarter 2024 Earnings Conference Call	04/04	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués AbbVie Inc.

Actions

ABBV

US00287Y1091

Communiqués

Filtres